Ventracor Limited Appoints Destination Therapy Trial Principal Investigator For LVAD

Sydney, Mar 13, 2008 (ABN Newswire) - Ventracor (ASX: VCR)(US ADR:VTCRY) announced today the appointment of Professor Mariell Jessup as Cardiology Principal Investigator of the US Destination Therapy Trial of the VentrAssist Left Ventricular Assist Device (LVAD).
MORE ON THIS TOPIC